INTRODUCTION
Majority of the breast pathologies initially present as a lump. It is important to establish a definitive diagnose of the lump, as it can be a malignant lesion. Detection of malignant lesion leads to early initiation of definitive treatment or its exclusion saves the patient from unnecessary medication and psychological trauma. It is difficult to establish the nature of the lesion merely on the clinical examination. If only clinical examination is done, the chances of accurate detection of the nature of the lump are only 70%. 1 To increase the accuracy of the diagnosis, physical examination must be supported by laboratory and radiological investigations. There are many techniques available, which can help in establishing the definitive diagnosis. Three of these tests are commonly used, mammography, ultrsonography and fine needle aspiration cytology (FNAC). However, the diagnostic accuracy of these tests, individually, is reported to be 82%, 82%, 78% respectively. [2] [3] [4] However if these tests are combined then the accuracy can be significantly increased, almost reaching to 100%. The combination of clinical examination, mammography and fine needle aspiration cytology (FNAC) is referred as "triple test", and its diagnostic accuracy is reported to be almost 100%.
"modified triple test", and its diagnostic accuracy is also as high as 100%. 9, 10 However all these studies were conducted in urban population and majority are conducted in developed country.
The diagnostic performance of "triple test" has not been tested in rural Indian population. So, the study was planned to evaluate the diagnostic accuracy of clinical examination, mammography and fine needle aspiration cytology (FNAC) individually and as a "triple test".
METHODS
The present hospital-based study was conducted in the department of General Surgery, Ashiwini Rural Medical College, Hospital ad Research Centre, Solapur. Inclusion and exclusion criteria for the study subjects were as follows.
Inclusion criteria
• Women, above the age of 30 years, presenting with a palpable lump in breast.
• Women, who are ready to participate in the study and give consent for all the diagnostic tests under "triple test" and biopsy for histopathological examination.
Exclusion criteria
• Pregnant women • Women presenting with breast abscess • Lumps with ulcerations, necrosis or other major skin lesions involving breast area.
Included women were initially clinically examined and then mammography as well as FNAC was done. During the mammography standard views -Cranio-caudal (CC) and medio-lateral oblique (MLO) views were taken for all the subjects. Additional views were also taken wherever necessary. Each of the result was classified into any one of these three categories, benign, malignant and suspicious. All suspicious results were finally included in the category of malignant lesions. The results of clinical examination, mammography and FNAC were compared with those of histopathological examination. "Triple test" was considered as concordant, only if all the three results were same, as malignant or benign. If any of these three results were different than the other two, then "triple test" was considered as discordant.
The concordant results of the "triple test" were compared with those of the histopathological examination. Sensitivity, specificity, positive and negative predictive values were calculated for each of these tests and for "triple test". Kappa statistics, a measure for inter-rater agreement (here, agreement between gold standard and the test) was calculated for each of these tests.
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RESULTS
Total of 154 women with same number of breast lesions were included in the study. Table 1 shows the age-wise distribution of the patients. The mean age of the patients was 43.53±7.38. Maximum patients were in the age group of 40 -44 followed by 45-49. Histopathological examination of 154 lesions confirmed that 115 lesions were benign and remaining 39 lesions were malignant. However, clinical examination detected 42 lesions as malignant, which included 13 false positive results and remaining 29 were true positives. Table 2 shows the comparison of the clinical examination and histopathological examination. The sensitivity, specificity, positive predictive value and negative predictive value of clinical examination in this study were 74.36%, 88.70%, 69.05% and 91.07%. The overall accuracy of clinical examination was found to be 85.06%. The kappa coefficient for agreement between clinical examination and golden test was 0.615±0.073. 
DISCUSSION
The triple test is the evaluation of palpable breast masses by physical examination, mammography, and fine-needle aspiration (FNA) in women. 12 The present study was planned to evaluate the diagnostic efficacy of "triple test" in detection of malignant breast lesions. The study has showed that the sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy of "triple test" for concordant results were found to be 100 %. Previous studies conducted in different settings have also reported the same results of the triple test. 5, [13] [14] [15] In the present study, sensitivity and specificity of diagnostic clinical examination was found to be 74.36% and 88.70% which is in accordance with the most of published series. 5, 16 For mammography, sensitivity and specificity of diagnostic was found to be 92.31% and 93.91% which is similar findings of the most of published studies. 5, 17, 18 And for FNAC, sensitivity and specificity of diagnostic was found to be 92.31% and 93.04% which is in agreement with previous studies. 5, 13, 19 However, the study has revealed that the concordant results were possible in only 115 out of 154 lesions, i. e. in 74.68% lesions. So, the results of the triple test could be interpreted in only 74.68% of lesions. Remaining 25.32% lesions gave discordant results, so no interpretation could be drawn in these lesions. Almost similar findings were obtained study done by Kharkwal et al.
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CONCLUSION
Nevertheless, the study proved that the triple test is a useful diagnostic tool which can be used in almost three fourth of the breast lesions, for the accurate identification of malignant lesion.
